CUD Statistics & Prevalence

Cannabis Use Disorder by the Numbers

Cannabis use disorder is far more common than most people realize. The data below comes from large-scale epidemiological studies, national surveys, and peer-reviewed meta-analyses. These are not scare tactics — they are the best available evidence on a condition that affects millions of people.

Prevalence in the United States

According to the 2023 National Survey on Drug Use and Health (NSDUH), approximately 19.2 million Americans met criteria for past-year marijuana use disorder. To put that number in perspective, that is roughly the population of New York State.

Approximately 19.2 million Americans met criteria for past-year marijuana use disorder in 2023.

National Survey on Drug Use and Health (NSDUH), 2023

Who Develops CUD?

A meta-analysis of 21 studies produced these key findings:

• 22% of cannabis users develop CUD at some point — roughly one in five people who use cannabis.
• 9% of all people who ever try cannabis will develop CUD in their lifetime.
• 17% of those who begin using as teenagers develop CUD — nearly double the overall lifetime rate.
• Among daily users, the rate is substantially higher still.

A meta-analysis of 21 studies found that among people who use cannabis, roughly 22% develop cannabis use disorder.

PubMed, Meta-analysis of CUD Prevalence (2020)

How Does CUD Compare to Other Substance Use Disorders?

It is sometimes helpful to compare CUD rates to other substances. Cannabis has a lower dependence rate than many drugs, but a significantly larger user base means that the absolute number of people affected is enormous:

Cannabis is less addictive per-user than nicotine, alcohol, or cocaine. But with an estimated 52 million Americans using cannabis in the past year, even a 9% lifetime dependence rate produces enormous numbers of people who need support.

Withdrawal: More Common Than You Think

An analysis of studies involving more than 23,000 people found that 47% of regular cannabis users experienced withdrawal symptoms when they stopped. That is nearly half of all regular users. A landmark study by Budney et al. found that the magnitude and time course of cannabis withdrawal were comparable to tobacco withdrawal.

Nobody questions whether nicotine withdrawal is real. Cannabis withdrawal deserves the same acknowledgment.

An analysis of studies involving more than 23,000 participants found that 47% of regular cannabis users experienced withdrawal symptoms upon cessation.

PMC, "Clinical management of cannabis withdrawal" (2022)

The Potency Factor

One reason CUD prevalence is growing is that cannabis itself has changed dramatically:

• Historical THC levels: 3-5% THC in flower
• Current flower: Routinely exceeds 25% THC
• Concentrates (dabs, wax, shatter): 80% THC or higher

This is not your parents' cannabis. Preliminary evidence suggests that addiction potential is linked to THC content, and research shows that people who use high-potency products like concentrates report more intense withdrawal symptoms. The endocannabinoid system was not designed for these THC levels, and the brain adapts accordingly — building tolerance faster and creating stronger dependence.

Severity Distribution

CUD is diagnosed on a spectrum based on how many DSM-5 criteria a person meets within a 12-month period:

• Mild CUD (2-3 criteria): The most common presentation. Many people at this level may not realize they have a diagnosable condition.
• Moderate CUD (4-5 criteria): Cannabis use is causing noticeable disruption in daily life, relationships, or mental health.
• Severe CUD (6+ criteria): Significant impairment across multiple areas. Professional treatment is strongly recommended.

The most commonly endorsed criteria across all severity levels are a persistent desire to cut down, craving, and using in larger amounts or for longer than intended. Many people with mild CUD function well enough that they — and those around them — don't recognize the pattern as a clinical condition.

Key Risk Factors

Not everyone who uses cannabis develops CUD. Several factors increase the risk:

• Age of first use: Starting before age 18 increases the risk 4 to 7 times compared to adult-onset users.
• Frequency and duration: Daily or near-daily use over extended periods significantly increases risk.
• Product potency: Higher-THC products carry greater addiction potential.
• Genetics: Multiple genes influence susceptibility, though genetics alone are not deterministic.
• Co-occurring mental health conditions: Depression is a major risk factor — lifetime CUD rates in people with major depressive disorder reach 39%.
• Adverse childhood experiences: Trauma history increases vulnerability.
• Concurrent substance use: Using cannabis alongside tobacco, alcohol, or other substances increases CUD likelihood.

The Treatment Gap

Perhaps the most striking statistic is this one: only 16.5% of people with CUD receive any substance use treatment. Research examining 16 years of data found that CUD treatment utilization actually decreased over time. Common barriers include:

• Not knowing where to access treatment
• Not feeling ready to stop
• Inability to afford treatment
• Perceiving stigma or fearing occupational consequences
• Believing that cannabis problems don't warrant "real" treatment

This treatment gap is one of the reasons this site exists. Whether you are ready for professional treatment or just starting to question your use, you deserve access to honest, evidence-based information.

Only 16.5% of people with CUD receive any substance use treatment. CUD treatment utilization decreased over a 16-year study period.

ScienceDirect, "CUD and substance use treatment among U.S. adults" (2024)

Sources and Further Reading

• NCBI StatPearls (2025), "Cannabis Use Disorder"
• PubMed (2020), Meta-analysis of CUD Prevalence
• ScienceDirect (2024), CUD and Substance Use Treatment Among U.S. Adults
• PMC (2022), "Clinical Management of Cannabis Withdrawal"
• Wikipedia, Cannabis Use Disorder (well-sourced overview)